Biocryst Pharmaceuticals (BCRX) Shareholder's Equity Growth (5y) (2015 - 2026)
Biocryst Pharmaceuticals (BCRX) Shareholder's Equity Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Biocryst Pharmaceuticals | 2.02 Bn | 1.78 Bn | 151.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.17% |
| Dec 31, 2025 | -43.97% |
| Sep 30, 2025 | -68.37% |
| Jun 30, 2025 | -49.67% |
| Mar 31, 2025 | -163.02% |
| Dec 31, 2024 | -70.58% |
| Sep 30, 2024 | -62.58% |
| Jun 30, 2024 | -120.17% |
| Mar 31, 2024 | -87.47% |
| Dec 31, 2023 | -62.27% |
| Sep 30, 2023 | -50.18% |
| Jun 30, 2023 | -59.79% |
| Mar 31, 2023 | -48.78% |
| Dec 31, 2022 | -40.71% |
| Sep 30, 2022 | -34.56% |
| Jun 30, 2022 | -61.12% |
| Mar 31, 2022 | -44.33% |
| Dec 31, 2021 | -133.76% |
| Sep 30, 2021 | -107.89% |
| Jun 30, 2021 | -58.25% |